1. RETRACTED: MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway
   Wei-Wei Wang et al, 2019, eBioMedicine CrossRef
2. Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis
   Padacherri Vethil Jishnu et al, 2020, Clinical & Experimental Metastasis CrossRef
3. Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer
   Jiaping Chen et al, 2018, Gene CrossRef
4. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1
   Peiqin Wang et al, 2019, Biochemistry and Cell Biology CrossRef
5. Novel Small Molecules Capable of Blocking mtRAS-Signaling Pathway
   Namkyoung Kim et al, 2021, Frontiers in Oncology CrossRef
6. Exosome miR‐134‐5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1
   Chao Yang et al, 2021, Journal of Obstetrics and Gynaecology Research CrossRef
7. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
   Khubaib Ali et al, 2024, Medical Oncology CrossRef
8. MiR‐134‐5p attenuates neuropathic pain progression through targeting Twist1
   Li‐Juan Ji et al, 2019, Journal of Cellular Biochemistry CrossRef
9. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
   Maryam Abolghasemi et al, 2020, Journal of Cellular Physiology CrossRef
10. miRNome Profiling Reveals Shared Features in Breast Cancer Subtypes and Highlights miRNAs That Potentially Regulate MYB and EZH2 Expression
    Stephany Corrêa et al, 2021, Frontiers in Oncology CrossRef
11. Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
    Chia Yin Goh et al, 2020, Cancer Letters CrossRef
12. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer
    Manosi Banerjee et al, 2023, Molecules CrossRef
13. miR‑202 acts as a potential tumor suppressor in breast cancer
    Shanshan Gao et al, 2018, Oncology Letters CrossRef
14. MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS
    Zhi-liang Wang et al, 2018, Carcinogenesis CrossRef
15. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis
    Junlin Chi et al, 2019, Biomedicine & Pharmacotherapy CrossRef
16. Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer
    Ziwei Jiang et al, 2021, BMC Complementary Medicine and Therapies CrossRef
17. miR‐134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo
    Cheng‐long Chen et al, 2019, FEBS Letters CrossRef